(NP (NP (NP (NN 1,25-Dihydroxyvitamin) (NN D3) (NN receptor) (NN RNA)) (: :)) (NP (NP (NN expression)) (PP (IN in) (NP (JJ hematopoietic) (NNS cells))) (. .)))
(S (S (NP-SBJ (NP (NN 1,25-Dihydroxyvitamin) (NN D3)) (PRN (-LRB- -LCB-) (NP (NN 1,25-LRB-OH-RRB-2D3)) (-RRB- -RCB-))) (VP (VP-COOD (VP (VBZ induces) (NP (NP (NN differentiation)) (PP (-NONE- *RNR*-55)))) (CC and) (VP (VBZ inhibits) (NP (NP (NN proliferation)) (PP (-NONE- *RNR*-55))))) (PP-55 (IN of) (NP (NP (JJ myeloid) (JJ leukemic) (NNS cells)) (PP (IN from) (NP (JJ various) (NP-COOD (NP (NNS lines)) (CC and) (NP (NNS patients)))))))) (: ;)) (S (NP-SBJ-56 (DT these) (NNS effects)) (VP (VBP are) (ADVP (RB probably)) (VP (VBN mediated) (NP (-NONE- *-56)) (PP (IN through) (NP (DT the) (NN 1,25-LRB-OH-RRB-2D3) (NN receptor))))) (. .)))
(S (NP-SBJ-58 (NP (JJ Little)) (PP (-NONE- *ICH*-57))) (VP (VBZ is) (VP (VBN known) (NP (-NONE- *-58)) (PP-57 (IN of) (NP (NP (NN expression)) (PP (IN of) (NP (NN 1,25-LRB-OH-RRB-2D3) (NN receptor) (NN RNA))) (PP (IN in) (NP (JJ hematopoietic) (NNS cells))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBD examined) (NP (NP (DT the) (NP-COOD (NP (NN expression)) (CC and) (NP (NP (NN modulation)) (PP (IN of) (NP (NP (NN expression))))))) (PP (IN of) (NP (NN 1,25-LRB-OH-RRB-2D3) (NN receptor) (NN RNA))) (PP (IN in) (NP (JJ various) (ADJP-COOD (ADJP (VBG proliferating)) (CC and) (ADJP (JJ nonproliferating))) (JJ hematopoietic) (NNS cells))))) (. .))
(S (NP-SBJ-60 (NP (JJ Constitutive) (NN expression)) (PP (IN of) (NP (NN 1,25-LRB-OH-RRB-2D3) (NN receptor) (NN RNA)))) (VP (VBD was) (VP (VBN detected) (NP (-NONE- *-60)) (PP-COOD (PP (IN in) (NP (NP (JJ various) (NNS kinds)) (PP (IN of) (NP (NP (JJ hematopoietic) (NNS cells)) (, ,) (PP (VBG including) (NP-COOD (NP (NNS macrophages)) (CC and) (NP (VBN activated) (NN T) (NNS lymphocytes)))) (, ,))))) (CONJP (RB as) (RB well) (IN as)) (PP (IN in) (NP (NN cell) (NNS lines) (NP-COOD (NP (NP (NN KG-1)) (PRN (-LRB- -LRB-) (NP (NNS myeloblasts)) (-RRB- -RRB-))) (, ,) (NP (NP (NN HL-60)) (PRN (-LRB- -LRB-) (NP (NNS promyelocytes)) (-RRB- -RRB-))) (, ,) (NP (NP (NN ML-3)) (PRN (-LRB- -LRB-) (NP (NNS myelomonoblasts)) (-RRB- -RRB-))) (, ,) (NP (NN U937)) (, ,) (NP (NP (NN THP-1)) (PRN (-LRB- -LRB-) (NP (NNS monoblasts)) (-RRB- -RRB-))) (, ,) (NP (NP (NN K562)) (PRN (-LRB- -LRB-) (NP (NNS erythroblasts)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (NN S-LB1)) (PRN (-LRB- -LRB-) (NP (JJ HTLV-1-transfected) (NN T) (NNS lymphocytes)) (-RRB- -RRB-))))))))) (. .))
(S-COOD (S (NP-SBJ (NN Receptor) (NNS transcripts)) (VP (VBD were) (NP-PRD (CD 4.6) (NP (NP (NNS kilobases)) (PRN (-LRB- -LRB-) (NP (NN kb)) (-RRB- -RRB-)))))) (, ,) (CC and) (S (NP-SBJ-61 (DT no) (JJ variant) (NNS sizes)) (VP (VBD were) (VP (VBN observed) (NP (-NONE- *-61))))) (. .))
(S (NP-SBJ (NP (DT All) (NN cell) (NNS lines)) (VP (VBN examined) (NP (-NONE- *)) (PP (IN in) (NP (DT this) (NN group))))) (ADVP (RB also)) (VP (VBD expressed) (NP (NN 1,25-LRB-OH-RRB-2D3) (NNS receptors))) (. .))
(S-COOD (S (NP-SBJ (JJS Most) (NN B) (NN lymphocyte) (NNS lines)) (VP (VBD expressed) (NP (NP (JJ negligible) (NNS levels)) (PP (IN of) (NP-COOD (NN 1,25-LRB-OH-RRB-2D3) (NN receptor) (NN RNA) (CC and) (NN protein)))))) (: ;) (RB however) (: ;) (S (NP-SBJ (NP (NN analysis)) (PP (IN of) (NP (DT a) (JJ (myeloid lymphoid)) (JJ somatic) (NN hybrid)))) (VP (VBD suggested) (SBAR (IN that) (S (NP-SBJ (NP (NN suppression)) (PP (IN of) (NP (NP (NN expression)) (PP (IN of) (NP (NN 1,25-LRB-OH-RRB-2D3) (NN receptor) (NN RNA))))) (PP (IN in) (NP (NN B) (NNS lymphocytes)))) (VP (MD may) (VP (VB be) (NP-PRD (DT a) (JJ dominant) (NN characteristic)))))))) (. .))
(S-COOD (S (NP-SBJ-64 (NN HL-60) (NNS cells)) (VP (VBD were) (VP (VBN cultured) (NP (-NONE- *-64)) (PP (IN with) (NP (NP (CD 10-LRB--7-RRB-) (NN (L mol))) (NP (NN 1,25-LRB-OH-RRB-2D3)))) (PP-TMP (IN for) (NP (QP (CD 24) (TO to) (CD 72)) (NNS hours)))))) (, ,) (CC and) (S (NP-SBJ-62 (NP (NNS levels)) (PP (IN of) (NP (NP (NN expression)) (PP (IN of) (NP-COOD (NP (NN 1,25-LRB-OH-RRB-2D3) (NN receptor)) (CC and) (NP (PRP$ its) (NN RNA))))))) (VP (VBD were) (VP (VBN examined) (NP (-NONE- *-62))))) (. .))
(S (NP-SBJ-63 (NP (NNS Levels)) (PP (IN of) (NP (NP (NN RNA)) (VP (NN coding) (PP (IN for) (NP (DT the) (NN receptor))))))) (VP (VBD were) (RB not) (VP (VBN modulated) (NP (-NONE- *-63)) (PP (IN by) (NP (NP (NN exposure)) (PP (TO to) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NN ligand))))))))) (. .))
(S-COOD (S (NP-SBJ (NP (NNS Levels)) (PP (IN of) (NP (VBN occupied) (NN 1,25-LRB-OH-RRB-2D3) (NN receptor) (NN protein)))) (VP (VBD increased) (PP (IN in) (NP (DT these) (NN HL-60) (NNS cells))))) (: ;) (CC but) (S (NP-SBJ (NP (DT the) (JJ total) (NN number)) (PP (IN of) (NP (NN 1,25-LRB-OH-RRB-2D3) (NNS receptors)))) (VP-COOD (VP (VBD decreased) (NP (QP (RB about) (CD 50)) (NN %)) (PP-TMP (IN at) (NP (CD 24) (NNS hours)))) (CC and) (VP (VBD returned) (PP (IN toward) (NP (JJ normal))) (PP-TMP (IN at) (NP (CD 72) (NNS hours)))))) (. .))
(S (NP-SBJ-65 (NP (JJ Steady-state) (NNS levels)) (PP (IN of) (NP (NN 1,25-LRB-OH-RRB-2D3) (NN receptor) (NN RNA)))) (VP (VBD were) (RB not) (VP (VBN affected) (NP (-NONE- *-65)) (PP (IN by) (NP-LGS (NP (JJ terminal) (NN differentiation)) (PP (IN of) (NP (NN HL-60))) (PP (IN toward) (NP-COOD (CC either) (NP (NNS granulocytes)) (CC or) (NP (NNS macrophages)))))))) (. .))
(S (NP-SBJ (NP (JJ Nondividing) (NNS macrophages)) (PP (IN from) (NP (JJ normal) (NNS individuals)))) (ADVP (RB also)) (VP (VBD expressed) (NP (NN 1,25-LRB-OH-RRB-2D3) (NN receptor) (NN RNA))) (. .))
(S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NP (JJ nondividing) (JJ peripheral) (NN blood) (NNS lymphocytes)) (PP (IN from) (NP (JJ normal) (NNS individuals)))) (VP (VBD did) (RB not) (VP (VB express) (NP (NN 1,25-LRB-OH-RRB-2D3) (NN receptor) (NN RNA)))) (: ;)) (S (PP (IN with) (NP (NP (NN stimulation)) (PP (IN of) (NP (NP (NN proliferation)) (PP (IN of) (NP (DT these) (NNS cells))))))) (, ,) (NP-SBJ (NP (NN accumulation)) (PP (IN of) (NP (NN 1,25-LRB-OH-RRB-2D3) (NN receptor) (NN RNA)))) (VP (VBD increased) (ADVP (RB markedly))) (. .)))
(S (NP-SBJ (NP (NP (NN Half-life)) (PRN (-LRB- -LRB-) (NP (NN (2 t1))) (-RRB- -RRB-))) (PP (IN of) (NP (NP (NN 1,25-LRB-OH-RRB-2D3) (NN receptor) (NN RNA)) (PP (IN in) (NP (NN T) (NNS lymphocytes)))))) (VP (VBD was) (ADJP-PRD (ADJP (JJ short)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN hour)) (-RRB- -RRB-))) (SBAR (IN as) (S (NP-SBJ-66 (-NONE- *)) (VP (VBN determined) (NP (-NONE- *-66)) (PP (IN by) (S (NP-SBJ (-NONE- *)) (VP (VBG measuring) (NP (NP (NN decay)) (PP (IN of) (NP (DT the) (NN message))) (PP-TMP (IN after) (NP (NP (NN addition)) (PP (IN of) (NP (NN actinomycin) (NN D))))))))))))) (. .))
(S (S-ADV (NP-SBJ (-NONE- *-67)) (ADJP-PRD (JJ Consistent) (PP (IN with) (NP (DT this) (JJ short) (NN (2 t1)))))) (, ,) (NP-SBJ-67 (NP (NN accumulation)) (PP (IN of) (NP (NN 1,25-LRB-OH-RRB-2D3) (NN receptor) (NN RNA)))) (VP (VBD increased) (PP (IN in) (NP (NNS cells))) (SBAR (IN as) (S (NP-SBJ-68 (PRP$ their) (NN protein) (NN synthesis)) (VP (VBD was) (VP (VBN inhibited) (NP (-NONE- *-68))))))) (. .))
(S (NP-SBJ-69 (JJ Further) (NNS studies)) (VP (VBP are) (VP (VBN required) (NP (-NONE- *-68)) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB understand) (NP (NP (DT the) (JJ physiologic) (NN role)) (PP (IN of) (NP (NN 1,25-LRB-OH-RRB-2D3) (NNS receptors))) (PP (IN in) (NP-COOD (NP (JJ myeloid) (NNS cells)) (CC and) (NP (VBG proliferating) (NN T) (NNS lymphocytes)))))))))) (. .))
